• Medical focus

• Article: A Closer Look at Beta Thalassaemia Intermedia
• Article: How to select iron chelators in 2011
• Article: Hydroxyurea Management in Patients with Beta Thalassemia Intermedia
• Article: Gene therapy for beta-thalassemia: results from the first trial
• Article: HbE Syndromes
• Article: Growth and Puberty in Thalassaemia (Skordis and Kyriakou, 2008)
• Article: Haemolysis-associated pulmonary hypertension in sickle cell disease and thalassaemia
• Commentary: Sickle cell as a paradigm of immigration haematology
• Article: Overview of the cardioprotective role of Deferiprone (M Angastiniotis, 2008)
• Literature review - May 2008
• Literature review - September 2008
• Frequently Asked Questions
• Back to homepage

This section includes scientific articles, summaries, updates and new information on subjects of medical interest, as well as policy documents relevant to our activities and of interest to medical professionals, TIF members, patients and their families as well as other interested individuals. The policy section includes for example EU directives, discussion papers and public consultation documents.

The scientific information contained here is for educational purposes only and should not be used to substitute for informed medical advice.

All medical information is reviewed and updated every year by the medical advisor, Dr Michael Angastiniotis, MD, DCH (Paediatrician)

Disclaimer

The contents of any scientific article or presentation of any material by manufacturers does not imply the expression of any opinion on the part of the Thalassaemia International Federation. The mention of specific companies or products does not imply that they are endorsed or recommended by TIF in preference to others. The contents express the opinions of the authors who alone are responsible for the views expressed. TIF does not accept any legal responsibility for the contents.